Blog
0
Poor End-of-Life Care Can Have Negative Impact on Patients and Caregivers
0

For patients with cancer and their caregivers, high quality end-of-life care is incredibly important, as one expert explained.“There has been a fair amount ...

0
Proteins, Cell Patterns May Explain Prostate Cancer Therapy Resistance
0

Researchers found that looking at cell patterns and proteins may help determine a way to target prostate cancer tumors resistant to hormone therapy and open ...

0
Can We Be Thankful in the Midst of Cancer?
0

Two weeks ago, most Americans celebrated Thanksgiving Day with family and/or friends. Among those who participated in holiday gatherings were individuals ...

0
FDA OKs Trial of TIL Therapy in Skin, Head and Neck and Lung Cancers
0

The Food and Drug Administration (FDA) OKs a phase 1/2 clinical trial of KSQ-001EX for the treatment of patients with melanoma, head and neck squamous cell ...

0
Cervical Cancer: Insight into the Patient Experience
0

Experts on cervical cancer offer provide comprehensive insights on the challenges patients experience and discuss ways to improve care.

0
From Existential Crisis to Existential Growth After Cancer
0

"Being a psychotherapist significantly helped me on my journey but did not save me from an existential crisis." After being diagnosed with triple-negative ...

0
Myths Around Cervical Cancer
0

The panel concludes their discussion with a conversation about the myths surrounding the treatment of cervical cancer.

0
Lung cancer screening could save thousands of lives in Scotland, Wales and Northern Ireland – Cancer Research UK
0

Thousands of lives could be saved from lung cancer if screening programmes for the disease were introduced in Scotland, Wales and Northern Ireland, ...

0
FDA Grants Priority Review for Padcev Plus Keytruda in Bladder Cancer
0

The Food and Drug Administration (FDA) has granted priority review for the supplemental Biologics License Application of Padcev (enfortumab vedotin-ejfv) ...

0
Immunotherapy Increases Risk of Side Effects, But Not Death
0

Adding immune checkpoint inhibitors to neoadjuvant and adjuvant therapy can increase the occurrence of treatment-related side effects, leading to treatment ...

0
Augtyro ‘Fills a Gap’ in the Treatment of ROS1-Positive NSCLC
0

The next-generation tyrosine kinase inhibitor Augtyro (repotrectinib) represents a new treatment option for patients with locally advanced (cancer that has ...

0
Tooth and Root Damage From Chemotherapy
0

My doctors and nurses always reminded me that chemotherapy kills fast-growing cells, like cancer. Many parts of our body are composed of fast-growing cells, ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart